They include, among others, IL13Rα2, EphA2, WT1, and survivin (108) and the antigens composing the IMA950 peptide cocktail (56), which were eluted from the surface of GBM cells and were shown to be expressed by the majority of patients with GBM (56). Here, BIRC5 is linked to glioblastoma.